Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil pharmacokinetic interaction study with oxcarbazepine in adults with epilepsy
NL-OMON46271Phase 1Completed
- Sponsor
- UCB
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of padsevonil and oxcarbazepine in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Padsevonil maximum observed plasma concentration at steady state, Padsevonil time to maximum concentration at steady state and 2 more. Started Sep 2018; status: completed.
02
Drugs
padsevoniloxcarbazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON46271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46271.